CT scan not necessary to diagnose cancer in patients with unexplained blood clots
the ONA take:
According to a new study published in the New England Journal of Medicine, researchers have found that a CT scan of the abdomen and pelvis does not improve cancer detection in people with unexplained deep vein thromboemboli and pulmonary emboli.
For the study, researchers enrolled 854 patients with unexplained blots in the legs, lungs, or both. Patients were randomly assigned to receive basic cancer screening with or without a CT scan of the abdomen and pelvis.
Basic cancer screening involved laboratory blood tests, a chest x-ray, and if applicable, a breast exam, prostate exam, or pap smear.
Results showed there was no difference in the incidence of new cancers between the two groups. Researchers found that about 4% of each group was diagnosed with cancer within the next year.
The study also demonstrated no difference in the number of cancer-related deaths between the two treatment arms.
The findings are expected to ultimately improve patient care and lower screening costs globally.
CT scan of the abdomen and pelvis does not improve cancer detection in people with unexplained deep vein thromboemboli.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Pediatric Hepatocellular Carcinoma: Challenges and Solutions
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- VBPWPs Can Compliment Patient Management in Clinical Trials
- Communication Technology Improves Treatment Burden, Patient Perspective of Oncology Care
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|